Dr. Adam Clark Seegmiller, MD

Dr. Seegmiller practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Seegmiller's NPI, 1225231772, was assigned on June 11, 2007. Dr. Seegmiller graduated from University of Texas Southwestern Medical School at Dallas in 2004. Dr. Seegmiller holds Tennessee license 44685.

Dr. Seegmiller's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Dr. Seegmiller's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. Dr. Seegmiller is also affiliated with Vanderbilt Wilson County Hospital. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Seegmiller to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Seegmiller practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology is Dr. Seegmiller's primary specialty in the NPI Registry, under taxonomy code 207ZH0000X. Dr. Seegmiller is licensed in Tennessee.

CMS data shows 1,025 Medicare services from Dr. Seegmiller across 13 procedure codes in 2024, for 496 Medicare patients. Medicare paid $17,814 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 496 Medicare patients who saw Dr. Seegmiller in 2024. The largest group is 65 to 74, with 231 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Seegmiller's median patient age at 66, with 54% women.

Dr. Seegmiller accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 16 papers to Dr. Seegmiller, published from 2018 to 2024. 2021 was the busiest year, with 4. The most frequent topics are COVID-19, Immunophenotyping and Leukemia, Myeloid, Acute. Dr. Seegmiller has published most often in Blood Adv. Dr. Seegmiller's most frequent co-authors are Ritu Banerjee, MD, Amy Elizabeth Dezern, MD and Natasha B. Halasa, MD.

CMS Open Payments shows 1 general payment to Dr. Seegmiller from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Celgene Corporation paid the most, $105.

Dr. Seegmiller graduated from University of Texas Southwestern Medical School at Dallas in 2004.